The ACC has published a scientific statement regarding the use of gene editing therapy for cardiovascular disease.

NIH-funded UT team and colleagues from Metagenomi Thereapeutics discovered highly efficient enzyme could enable targeted gene editing within the human body.

Invasive species represent a $5.4 trillion global problem, with U.S. economic impact alone exceeding $500 billion annually.

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling ...

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling precise correction ...

The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling precise correction, ...

In heart failure, the heart can no longer supply the body with enough blood. The condition often develops over many years, ...

When CRISPR cuts a gene flanked by short, repeating DNA sequences, the cell’s repair machinery gets confused. It simply zips ...

Scientists are on the brink of not just editing our genes to treat diseases, but to enhance humanity – including how much we ...

Gene drives—a genetic engineering approach that quickly spreads specific genetic changes throughout a population, whether to ...

Trace the timeline of CRISPR-Cas9 from its 2012 discovery to the latest AI-driven advancements and "N-of-1" clinical ...